Impinj Analysts Boost Their Forecasts After Q1 Results

Impinj, Inc. (NASDAQ:PI) reported better-than-expected first-quarter financial results on Wednesday. Impinj posted adjusted earnings of 21 cents per…

Impinj, Inc. (NASDAQ:PI) reported better-than-expected first-quarter financial results on Wednesday.

Impinj posted adjusted earnings of 21 cents per share, beating market estimates of 11 cents per share. The company’s quarterly sales came in at $76.83 million versus expectations of $73.57 million, according to data from Benzinga Pro.

“2024 started strong, with revenue and profitability exceeding both our fourth-quarter results and first-quarter guidance,” said Chris Diorio, Impinj co-founder and CEO. “As we continue driving our bold vision to connect every item in our everyday world, I remain confident in our market position and energized by the opportunities ahead.”

Impinj said it sees second-quarter non-GAAP EPS of 72 cents to 77 cents and revenue of $96 million to $99 million.

Impinj shares fell 2.2% to close at $120.91 on Wednesday.

These analysts made changes to their price targets on Impinj following earnings announcement.

  • Needham boosted the price target on Impinj from $130 to $160. Needham analyst James Ricchiuti maintained a Buy rating.
  • Piper Sandler boosted the price target on Impinj from $130 to $150. Piper Sandler analyst Harsh Kumar reiterated an Overweight rating.

Now Check This Out: Jim Cramer: You’re ‘Dice Rolling’ With This Biopharma Stock, But Vista Energy Is ‘A Good Situation’

Total
0
Shares
Related Posts
Read More

Sight Sciences Announces New, Large-Scale MIGS Data From 41st Congress Of ESCRS Demonstrating TCOR™ Using OMNI Surgical System Technology Is Effective At Lowering Both IOP And IOP Reducing Medications At 2 Years In Patients With Glaucoma

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced

SGHT